期刊文献+

河南省抗GQ1b抗体综合征患者临床特点分析 被引量:1

Clinical characteristics of patients with anti-GQ1b antibody syndrome in Henan Province
下载PDF
导出
摘要 目的:分析河南省抗GQ1b抗体综合征患者的临床特点。方法:对815例临床怀疑周围神经病患者的血清进行抗神经节苷脂抗体检测,分析确诊为抗GQ1b抗体综合征的22例患者的临床特点。将22例患者按血清是否单一抗GQ1b抗体阳性分为2组,分析两组间临床表现不同点;将患者按应用一线免疫药物治疗(17例)和临床对症治疗(5例)分为2组,比较2组疗效的差异。结果:22例患者中男10例,女12例,有前驱感染病史14例,主要临床表现为四肢无力、腱反射减弱或消失、球麻痹;脑脊液蛋白-细胞分离9例。血清仅抗GQ1b抗体1项阳性者4例,均无意识障碍发生;多抗体阳性18例,其中伴有意识障碍发生的有5例。一线免疫治疗较临床对症治疗疗效更好(P=0. 018)。4例患者经一线免疫治疗8~12 d后血清抗GQ1b抗体转阴性。结论:抗GQ1b抗体综合征临床症状复杂,其中意识障碍的发生可能有多种抗体共同参与,根据临床特点、脑脊液检查和血清GQ1b抗体可明确诊断;给予人免疫球蛋白或激素治疗预后良好。 Aim: To analyze the clinical features of patients with anti-GQ1 b antibody syndrome in Henan Province.Methods: The anti-ganglioside antibody was detected in 815 patients with clinically suspected peripheral neuropathy,and the clinical features of 22 patients diagnosed as anti-GQ1 b antibody syndrome were analyzed. The 22 patients were allocated into two groups based on whether their serum was positive for the single anti-GQ1 b antibody,and the clinical manifestations were analyzed. The 22 patients were allocated into two groups according to the application of first-line immunotherapy( 17 cases) and clinical symptomatic treatment( 5 cases),and the non-parametric Kruskal-Wallis test was used to analyze the difference treatment effects. Results: Among the 22 patients,10 were male and 12 were female. There were 14 cases of pre-infection history. The main clinical manifestations were limb weakness,decreased or absent tendon reflex,and bulbar paralysis. Furthermore,cerebrospinal fluid protein-cell separation was observed in 9 cases. Only 4 patients were positive for single anti-GQ1 b antibody,all of whom had not conscious disorder. Additionally,18 patients were positive for multiple antibodies,of whom 5 showed disturbance of consciousness. First-line immunotherapy was more effective than clinical symptomatic treatment,and the difference was statistically significant( P = 0. 018). Four patients were negative for serum anti-GQ1 b antibody after 8 ~ 12 days of first-line immunotherapy. Conclusion: The clinical symptoms of anti-GQ1 b antibody syndrome are complex. Among them,disturbance of consciousness may be caused by multiple antibodies. The diagnosis can be confirmed by clinical features,cerebrospinal fluid examination,and serum GQ1 b antibody. The prognosis of patients with human immunoglobulin or hormone therapy is good.
作者 李婷婷 张迎娜 吕杰 赵雪 张婧 孟云 任璐 方华 杨俊红 张运克 高峰 白宏英 LI Tingting;ZHANG Yingna;LYU Jie;ZHAO Xue;ZHANG Jing;MENG Yun;REN Lu;FANG Hua;YANG Junhong;ZHANG Yunke;GAO Feng;BAI Hongying(Department of Neurology,the Second Affiliated Hospital,Zhengzhou University,Zhengzhou 450014;Department of Neuroimmunology Research,Institute of Medical and Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450052;Department of Encephalopathy,the First Affiliated Hospital,Henan University of Traditional Chinese Medicine,Zhengzhou 450008)
出处 《郑州大学学报(医学版)》 CAS 北大核心 2019年第2期231-235,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目(81471545) 河南省自然科学基金资助项目(182300410294) 河南省高等学校重点科研项目(18A360001)
关键词 抗GQ1b抗体综合征 临床特点 河南省 anti-GQ1b antibody syndrome clinical features Henan Province
  • 相关文献

参考文献4

二级参考文献31

  • 1汤颖,王晔,王德生.Bickerstaff脑干脑炎一例报告[J].中华神经科杂志,2005,38(9):598-598. 被引量:3
  • 2Odaka M, Yuki N, Hirata K. Anti-GQlb IgG antibody syndrome: clinical and immunological range [ J ]. J Neurol Neurosurg Psychiatry, 2001, 70 (1): 50-55. DOI: 10. l136/jnnp. 70. 1. 50.
  • 3Guillain G. Les polyradiculon6vrites avec dissociation alumbinocytologique et 6 evolution favorable (Syndrome de Guillain et Barr6) [ J]. J Beige Nenrol Psychiat, 1938, 38 ( 1 ) : 323 -329.
  • 4Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis[ J]. Br Med J, 1951, 2(4723) : 77-81.
  • 5Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia) [J]. N Engl J Med, 1956, 255(2) : 57-65.
  • 6Bickerstaff ER. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis [ J ]. Br Med J, 1957, 1 (5032) : 1384-1387.
  • 7A1-Din AN, Anderson M, Bickerstaff ER, et al. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study [ J]. Brain, 1982, 105 (Pt 3 ) : 481-495. DOI : 10. 1093/brain / 105.3. 481.
  • 8Chiba A, Kusunoki S, Shimizu T, et al. Serum IgG antibody to ganglioside GQ1 b is a possible marker of Miller Fisher syndrome [ J]. Ann Neurol, 1992, 31 (6) : 677-679. DOI : 10. 1002/ana. 410310619.
  • 9Yuki N, Sato S, Tsnji S, et al. An immunologic abnormality common to Bickerstaff' s brain stem encephalitis and Fisher's syndrome[J]. J Neurol Sci, 1993, 118(1): 83-87. DOI: 10. 1016/0022-510X(93) 90250-3.
  • 10Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barr6 syndrome [ J ]. Brain, 2003, 126 (Pt 10) : 2279-2290. DO/: 10, 1093/brain/awg233.

共引文献45

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部